Update of the Common Package of Benefits of the Spanish National Health System from April 2026

On April 20, 2026, the Common Package of Benefits of the Spanish National Health System (NHS) was amended (by Order SND/356/2026, of April 13, 2026). The key changes relate to diagnostic imaging, in-vitro diagnostics, obstetrics and gynecology, and some other fields. Some examples are provided below:

Screening for preeclampsia was included in the prenatal screening program. The screening test is a first-trimester combined screening test for preeclampsia, consisting of a biochemical assessment with determination of PlGF (placental growth factor) or PAPP-A (glycoprotein synthesized in the trophoblast), an ultrasound assessment of the uterine artery pulsatility index (UtA-PI), and measurement of mean arterial pressure (MAP).

The package of public health services was updated by including multiple conditions (primary carnitine deficiency, propionic acidemia, isovaleric acidemia, severe combined immunodeficiency, spinal muscular atrophy, X-linked adrenoleukodystrophy, and some others) in the neonatal screening program. The Autonomous Communities and the Cities of Ceuta and Melilla, in coordination with the INGESA and the civil service mutual funds, shall adapt their respective service portfolios to the provisions of this order in relation to the neonatal screening program within one year of its entry into force.

To harmonize access criteria for in-vitro fertilization (IVF) with donor oocytes, the age limit previously set at under 36 years for patients with premature clinical ovarian failure was abolished. As a result, the same rule will apply as in other IVF cases with donor oocytes: the woman or transgender person retaining the capacity to gestate must be under 40 years of age at the time the treatment is indicated.

The full details in Spanish can be found here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.